Santen Pharmaceutical Co(SNPHY)
$12.52+0.04 (+0.31%)
SNPHY
Santen Pharmaceutical Co earnings date
$12.52
At close:+0.04 (+0.31%)
Want to see SNPHY full AI Analyst Report?
Santen Pharmaceutical Co (SNPHY) Q2 2026 Earnings Report
6 Followers
SNPHY Q2 2026 EPS Results
- Actual EPS
- $0.16
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- $0.17
SNPHY Q2 2026 Revenue Results
- Actual Revenue
- $466.76M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -0.48%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/05/2026
- Time
- TBA
- Conference Call
- Thursday, November 5, 2026
SNPHY Upcoming Earnings
Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
SNPHY Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
SNPHY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q3) | ―- | 0.16 | ― | ― |
| Nov 05, 2026 | 2026 (Q2) | ―0.16 | 0.17 | -3.01% (-0.01) | |
| Aug 06, 2026 | 2026 (Q1) | ―0.14 | 0.12 | 16.67% (+0.02) | |
| May 12, 2026 | 2025 (Q4) | ―0.31 | 0.17 | 82.25% (+0.14) | |
| Feb 05, 2026 | 2025 (Q3) | ―0.16 | 0.17 | -4.82% (-0.01) | |
| Nov 06, 2025 | 2025 (Q2) | ―0.17 | 0.16 | 6.41% (+0.01) | |
| Aug 07, 2025 | 2025 (Q1) | ―0.12 | 0.19 | -36.84% (-0.07) | |
| May 13, 2025 | 2024 (Q4) | ―0.17 | 0 | 16800.00% (+0.17) | |
| Feb 06, 2025 | 2024 (Q3) | ―0.17 | 0.14 | 18.57% (+0.03) | |
| Nov 07, 2024 | 2024 (Q2) | ―0.16 | 0.17 | -8.24% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
